Immucell Corp (ICCC) Reports Q1 Loss of $0.30
Tweet
Share
E-mailGet Alerts ICCC Hot Sheet
Price: $10.90 -0.73%
Financial Fact:
Income tax benefit: -10.91K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income tax benefit: -10.91K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Immucell Corp (NASDAQ: ICCC) reported Q1 EPS of ($0.30). Revenue for the quarter came in at $3.45 million, versus $0 reported last year.
For earnings history and earnings-related data on Immucell Corp (ICCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Immucell Corp (ICCC) Reports Q2 EPS of $0.20
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
